1887

Abstract

Canine distemper (CD) causes gastrointestinal and respiratory and/or neurological signs and results in high morbidity and mortality, remaining a threat to carnivores around the world. Live-attenuated vaccines have been widely used to reduce the number of CD outbreaks, but efforts are still needed to improve immune efficiency. Interleukin-7 (IL-7) has been reported to boost host immunity by recruiting follicle helper T (TFH) or germinal center (GC) B cells. Here, we constructed a recombinant canine distemper virus (rCDV) by reverse genetics and evaluated the properties of six intergenic sites for insertion of a foreign gene. We found that the P/M intergenic region was the optimal site to insert a foreign gene into the CDV genome. The effect of overexpressing IL-7 on rCDV immunogenicity was then evaluated in a mouse model. We found that mice immunized with rCDV-IL7 could not significantly enhance the maturation of dendritic cells (DCs) but significantly facilitated the generation of TFH cells, GC B cells and plasma cells (PCs), as well as the formation of GCs, consequently enhancing the production of CDV-specific neutralizing antibodies and total IgG. Together, these results suggested that the overexpression of IL-7 by rCDV could enhance humoral responses by activating the TFH–GC B–PC axis, which will help to improve vaccines for CD.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001247
2019-03-15
2019-12-09
Loading full text...

Full text loading...

References

  1. Zhao J, Shi N, Sun Y, Martella V, Nikolin V et al. Pathogenesis of canine distemper virus in experimentally infected raccoon dogs, foxes, and minks. Antiviral Res 2015;122:1–11 [CrossRef][PubMed]
    [Google Scholar]
  2. de Vries RD, Ludlow M, de Jong A, Rennick LJ, Verburgh RJ et al. Delineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets. PLoS Pathog 2017;13:e1006371 [CrossRef][PubMed]
    [Google Scholar]
  3. Seki F, Ono N, Yamaguchi R, Yanagi Y. Efficient isolation of wild strains of canine distemper virus in Vero cells expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. J Virol 2003;77:9943–9950 [CrossRef][PubMed]
    [Google Scholar]
  4. Fujita K, Miura R, Yoneda M, Shimizu F, Sato H et al. Host range and receptor utilization of canine distemper virus analyzed by recombinant viruses: Involvement of heparin-like molecule in CDV infection. Virology 2007;359:324–335 [CrossRef][PubMed]
    [Google Scholar]
  5. Sakai K, Yoshikawa T, Seki F, Fukushi S, Tahara M et al. Canine distemper virus associated with a lethal outbreak in monkeys can readily adapt to use human receptors. J Virol 2013;87:7170–7175 [CrossRef][PubMed]
    [Google Scholar]
  6. Rudd PA, Cattaneo R, von Messling V. Canine distemper virus uses both the anterograde and the hematogenous pathway for neuroinvasion. J Virol 2006;80:9361–9370 [CrossRef][PubMed]
    [Google Scholar]
  7. Alves L, Khosravi M, Avila M, Ader-Ebert N, Bringolf F et al. SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes. J Virol 2015;89:5724–5733 [CrossRef][PubMed]
    [Google Scholar]
  8. Gassen U, Collins FM, Duprex WP, Rima BK. Establishment of a rescue system for canine distemper virus. J Virol 2000;74:10737–10744 [CrossRef][PubMed]
    [Google Scholar]
  9. Otsuki N, Sekizuka T, Seki F, Sakai K, Kubota T et al. Canine distemper virus with the intact C protein has the potential to replicate in human epithelial cells by using human nectin4 as a receptor. Virology 2013;435:485–492 [CrossRef][PubMed]
    [Google Scholar]
  10. Yi L, Xu H, Wang J, Cheng Y, Zhang H et al. Complete nucleotide sequence of canine distemper virus CDV-PS, isolated from dogs in china. Genome Announc 2013;1: [CrossRef][PubMed]
    [Google Scholar]
  11. Riley MC, Wilkes RP. Sequencing of emerging canine distemper virus strain reveals new distinct genetic lineage in the United States associated with disease in wildlife and domestic canine populations. Virol J 2015;12:219 [CrossRef][PubMed]
    [Google Scholar]
  12. Sidhu MS, Husar W, Cook SD, Dowling PC, Udem SA. Canine distemper terminal and intergenic non-protein coding nucleotide sequences: completion of the entire CDV genome sequence. Virology 1993;193:66–72 [CrossRef][PubMed]
    [Google Scholar]
  13. Loots AK, Mitchell E, Dalton DL, Kotzé A, Venter EH. Advances in canine distemper virus pathogenesis research: a wildlife perspective. J Gen Virol 2017;98:311–321 [CrossRef][PubMed]
    [Google Scholar]
  14. Röthlisberger A, Wiener D, Schweizer M, Peterhans E, Zurbriggen A et al. Two domains of the V protein of virulent canine distemper virus selectively inhibit STAT1 and STAT2 nuclear import. J Virol 2010;84:6328–6343 [CrossRef][PubMed]
    [Google Scholar]
  15. Otsuki N, Nakatsu Y, Kubota T, Sekizuka T, Seki F et al. The V protein of canine distemper virus is required for virus replication in human epithelial cells. PLoS One 2013;8:e82343 [CrossRef][PubMed]
    [Google Scholar]
  16. Miura R, Kooriyama T, Yoneda M, Takenaka A, Doki M et al. Efficacy of recombinant canine distemper virus expressing leishmania antigen against leishmania challenge in dogs. PLoS Negl Trop Dis 2015;9:e0003914 [CrossRef][PubMed]
    [Google Scholar]
  17. Parks CL, Wang HP, Kovacs GR, Vasilakis N, Kowalski J et al. Expression of a foreign gene by recombinant canine distemper virus recovered from cloned DNAs. Virus Res 2002;83:131–147 [CrossRef][PubMed]
    [Google Scholar]
  18. de Vries RD, Ludlow M, de Jong A, Rennick LJ, Verburgh RJ et al. Delineating morbillivirus entry, dissemination and airborne transmission by studying in vivo competition of multicolor canine distemper viruses in ferrets. PLoS Pathog 2017;13:e1006371 [CrossRef][PubMed]
    [Google Scholar]
  19. Wang X, Feng N, Ge J, Shuai L, Peng L et al. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Vaccine 2012;30:5067–5072 [CrossRef][PubMed]
    [Google Scholar]
  20. Ludlow M, Nguyen DT, Silin D, Lyubomska O, de Vries RD et al. Recombinant canine distemper virus strain Snyder Hill expressing green or red fluorescent proteins causes meningoencephalitis in the ferret. J Virol 2012;86:7508–7519 [CrossRef][PubMed]
    [Google Scholar]
  21. Pekosz A, He B, Lamb RA. Reverse genetics of negative-strand RNA viruses: closing the circle. Proc Natl Acad Sci USA 1999;96:8804–8806 [CrossRef][PubMed]
    [Google Scholar]
  22. Thakkar VD, Cox RM, Sawatsky B, da Fontoura Budaszewski R, Sourimant J et al. The Unstructured paramyxovirus nucleocapsid protein tail domain modulates viral pathogenesis through regulation of transcriptase activity. J Virol 2018;92:e02064-17 [CrossRef][PubMed]
    [Google Scholar]
  23. Tremaglio CZ, Noton SL, Deflubé LR, Fearns R. Respiratory syncytial virus polymerase can initiate transcription from position 3 of the leader promoter. J Virol 2013;87:3196–3207 [CrossRef][PubMed]
    [Google Scholar]
  24. Shu B, Gong P. Structural basis of viral RNA-dependent RNA polymerase catalysis and translocation. Proc Natl Acad Sci USA 2016;113:E4005E4014 [CrossRef][PubMed]
    [Google Scholar]
  25. Venkataraman S, Prasad B, Selvarajan R. RNA dependent RNA polymerases: insights from structure, function and evolution. Viruses 2018;10:76 [CrossRef][PubMed]
    [Google Scholar]
  26. Welter J, Taylor J, Tartaglia J, Paoletti E, Stephensen CB. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines. J Virol 2000;74:6358–6367 [CrossRef][PubMed]
    [Google Scholar]
  27. Kapil S, Allison RW, Johnston L, Murray BL, Holland S et al. Canine distemper virus strains circulating among North American dogs. Clin Vaccine Immunol 2008;15:707–712 [CrossRef][PubMed]
    [Google Scholar]
  28. Cirone F, Elia G, Campolo M, Friedrich K, Martella V et al. Immunogenicity of an inactivated oil-emulsion canine distemper vaccine in African wild dogs. J Wildl Dis 2004;40:343–346 [CrossRef][PubMed]
    [Google Scholar]
  29. Peper ST, Peper RL, Mitcheltree DH, Kollias GV, Brooks RP et al. Utility of two modified-live virus canine distemper vaccines in wild-caught fishers (Martes pennanti). Vet Q 2016;36:197–202 [CrossRef][PubMed]
    [Google Scholar]
  30. von Messling V, Zimmer G, Herrler G, Haas L, Cattaneo R. The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol 2001;75:6418–6427 [CrossRef][PubMed]
    [Google Scholar]
  31. Confer AW, Kahn DE, Koestner A, Krakowka S. Biological properties of a canine distemper virus isolate associated with demyelinating encephalomyelitis. Infect Immun 1975;11:835–844[PubMed]
    [Google Scholar]
  32. Bi Z, Xia X, Wang Y, Mei Y. Development and characterization of neutralizing monoclonal antibodies against canine distemper virus hemagglutinin protein. Microbiol Immunol 2015;59:202–208 [CrossRef][PubMed]
    [Google Scholar]
  33. Wang F-X, Zhang S-Q, Zhu H-W, Yang Y, Sun N et al. Recombinant rabies virus expressing the H protein of canine distemper virus protects dogs from the lethal distemper challenge. Vet Microbiol 2014;174:362–371 [CrossRef]
    [Google Scholar]
  34. da Fontoura Budaszewski R, Hudacek A, Sawatsky B, Krämer B, Yin X et al. Inactivated recombinant rabies viruses displaying canine distemper virus glycoproteins induce protective immunity against both pathogens. J Virol 2017;91: [CrossRef][PubMed]
    [Google Scholar]
  35. Colombetti S, Lévy F, Chapatte L. IL-7 adjuvant treatment enhances long-term tumor-antigen-specific CD8+ T-cell responses after immunization with recombinant lentivector. Blood 2009;113:6629–6637 [CrossRef][PubMed]
    [Google Scholar]
  36. Li Y, Zhou M, Luo Z, Zhang Y, Cui M et al. Overexpression of interleukin-7 extends the humoral immune response induced by rabies vaccination. J Virol 2017;91: [CrossRef][PubMed]
    [Google Scholar]
  37. Seo YB, Im SJ, Namkoong H, Kim SW, Choi YW et al. Crucial roles of interleukin-7 in the development of T follicular helper cells and in the induction of humoral immunity. J Virol 2014;88:8998–9009 [CrossRef][PubMed]
    [Google Scholar]
  38. Hou H, Kang Y, Zeng Y, Li Y, Shang J. Interleukin-7 augments CD8+ T cells function and promotes viral clearance in chronic hepatitis C virus infection. Cytokine 2018;102:26–33 [CrossRef][PubMed]
    [Google Scholar]
  39. Meyer-Hermann M, Mohr E, Pelletier N, Zhang Y, Victora GD et al. A theory of germinal center B cell selection, division, and exit. Cell Rep 2012;2:162–174 [CrossRef][PubMed]
    [Google Scholar]
  40. Yang Y, Huang Y, Gnanadurai CW, Cao S, Liu X et al. The inability of wild-type rabies virus to activate dendritic cells is dependent on the glycoprotein and correlates with its low level of the de novo-synthesized leader RNA. J Virol 2015;89:2157–2169 [CrossRef][PubMed]
    [Google Scholar]
  41. Wang Z, Li M, Zhou M, Zhang Y, Yang J et al. A novel rabies vaccine expressing CXCL13 enhances humoral immunity by recruiting both T follicular helper and germinal center B cells. J Virol 2017;91: [CrossRef]
    [Google Scholar]
  42. Garrido-Cardenas JA, Garcia-Maroto F, Alvarez-Bermejo JA, Manzano-Agugliaro F. DNA Sequencing Sensors: An Overview. Sensors 2017;17:588 [CrossRef][PubMed]
    [Google Scholar]
  43. Wen G, Chen C, Guo J, Zhang Z, Shang Y et al. Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene. J Gen Virol 2015;96:1219–1228 [CrossRef][PubMed]
    [Google Scholar]
  44. Conradie AM, Stassen L, Huismans H, Potgieter CA, Theron J. Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus. Virology 2016;499:144–155 [CrossRef][PubMed]
    [Google Scholar]
  45. Jiang Y, Liu H, Liu P, Kong X. Plasmids driven minigenome rescue system for Newcastle disease virus V4 strain. Mol Biol Rep 2009;36:1909–1914 [CrossRef][PubMed]
    [Google Scholar]
  46. Schneider H, Spielhofer P, Kaelin K, Dötsch C, Radecke F et al. Rescue of measles virus using a replication-deficient vaccinia-T7 vector. J Virol Methods 1997;64:57–64 [CrossRef][PubMed]
    [Google Scholar]
  47. Habjan M, Penski N, Spiegel M, Weber F. T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J Gen Virol 2008;89:2157–2166 [CrossRef][PubMed]
    [Google Scholar]
  48. Kojima S, Honda T, Matsumoto Y, Tomonaga K. Heat stress is a potent stimulus for enhancing rescue efficiency of recombinant Borna disease virus. Microbiol Immunol 2014;58:636–642 [CrossRef][PubMed]
    [Google Scholar]
  49. Parks CL, Lerch RA, Walpita P, Sidhu MS, Udem SA. Enhanced measles virus cDNA rescue and gene expression after heat shock. J Virol 1999;73:3560–3566[PubMed]
    [Google Scholar]
  50. Lan NT, Yamaguchi R, Uchida K, Sugano S, Tateyama S. Growth profiles of recent canine distemper isolates on Vero cells expressing canine signalling lymphocyte activation molecule (SLAM). J Comp Pathol 2005;133:77–81 [CrossRef][PubMed]
    [Google Scholar]
  51. Silin D, Lyubomska O, Ludlow M, Duprex WP, Rima BK. Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J Virol 2007;81:13649–13658 [CrossRef][PubMed]
    [Google Scholar]
  52. Zhou M, Wang L, Zhou S, Wang Z, Ruan J et al. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs. Oncotarget 2015;6:38504–38516 [CrossRef][PubMed]
    [Google Scholar]
  53. Zhao L, Toriumi H, Wang H, Kuang Y, Guo X et al. Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells. J Virol 2010;84:9642–9648 [CrossRef][PubMed]
    [Google Scholar]
  54. Havenar-Daughton C, Lindqvist M, Heit A, Wu JE, Reiss SM et al. CXCL13 is a plasma biomarker of germinal center activity. Proc Natl Acad Sci USA 2016;113:2702–2707 [CrossRef][PubMed]
    [Google Scholar]
  55. Zipperle L, Langedijk JP, Orvell C, Vandevelde M, Zurbriggen A et al. Identification of key residues in virulent canine distemper virus hemagglutinin that control CD150/SLAM-binding activity. J Virol 2010;84:9618–9624 [CrossRef][PubMed]
    [Google Scholar]
  56. Lacy P, Stow JL. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood 2011;118:9–18 [CrossRef][PubMed]
    [Google Scholar]
  57. Fatkhullina AR, Peshkova IO, Koltsova EK. The role of cytokines in the development of Atherosclerosis. Biochemistry 2016;81:1358–1370 [CrossRef][PubMed]
    [Google Scholar]
  58. Yan Y, Niu L, Deng J, Wang Q, Yu J et al. Adjuvant effects of recombinant giant panda (Ailuropoda melanoleuca) IL-18 on the canine distemper disease vaccine in mice. J Vet Med Sci 2015;77:187–192 [CrossRef][PubMed]
    [Google Scholar]
  59. Yang J, Cornelissen F, Papazian N, Reijmers RM, Llorian M et al. IL-7-dependent maintenance of ILC3s is required for normal entry of lymphocytes into lymph nodes. J Exp Med 2018;215:1069–1077 [CrossRef][PubMed]
    [Google Scholar]
  60. MacKall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011;11:330–342 [CrossRef][PubMed]
    [Google Scholar]
  61. Hong JJ, Amancha PK, Rogers KA, Courtney CL, Havenar-Daughton C et al. Early lymphoid responses and germinal center formation correlate with lower viral load set points and better prognosis of simian immunodeficiency virus infection. J Immunol 2014;193:797–806 [CrossRef][PubMed]
    [Google Scholar]
  62. Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science 2007;315:528–531 [CrossRef][PubMed]
    [Google Scholar]
  63. Garin A, Meyer-Hermann M, Contie M, Figge MT, Buatois V et al. Toll-like receptor 4 signaling by follicular dendritic cells is pivotal for germinal center onset and affinity maturation. Immunity 2010;33:84–95 [CrossRef][PubMed]
    [Google Scholar]
  64. Ise W, Fujii K, Shiroguchi K, Ito A, Kometani K et al. T follicular helper cell-germinal center B cell interaction strength regulates entry into plasma cell or recycling germinal center cell fate. Immunity 2018;48:702–715 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001247
Loading
/content/journal/jgv/10.1099/jgv.0.001247
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error